These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Atherosclerotic plaque inflammation: the final frontier? Aikawa M; Libby P Can J Cardiol; 2004 May; 20(6):631-4. PubMed ID: 15152295 [No Abstract] [Full Text] [Related]
6. Pleiotropic effects of statins in atherosclerosis: role on endothelial function, inflammation and immunomodulation. Arnaud C; Mach F Arch Mal Coeur Vaiss; 2005 Jun; 98(6):661-6. PubMed ID: 16007821 [TBL] [Abstract][Full Text] [Related]
7. Statins for atherosclerosis--as good as it gets? Ehrenstein MR; Jury EC; Mauri C N Engl J Med; 2005 Jan; 352(1):73-5. PubMed ID: 15635116 [No Abstract] [Full Text] [Related]
8. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Libby P; Aikawa M Nat Med; 2002 Nov; 8(11):1257-62. PubMed ID: 12411953 [No Abstract] [Full Text] [Related]
9. Potential role of statins in inflammation and atherosclerosis. Yoshida M J Atheroscler Thromb; 2003; 10(3):140-4. PubMed ID: 14564082 [TBL] [Abstract][Full Text] [Related]
10. The role of statins in reversing atherosclerosis: what the latest regression studies show. Grines CL J Interv Cardiol; 2006 Feb; 19(1):3-9. PubMed ID: 16483333 [TBL] [Abstract][Full Text] [Related]
11. [Do anti-lipemic agents only work by their lipid-lowering effect?]. Paillard F; Guillo P Ann Cardiol Angeiol (Paris); 1999 Nov; 48(9-10):656-60. PubMed ID: 12555474 [No Abstract] [Full Text] [Related]
12. Bisphosphonates, statins, osteoporosis, and atherosclerosis. Watts N South Med J; 2002 Jun; 95(6):578-82. PubMed ID: 12081213 [No Abstract] [Full Text] [Related]
13. Novel faces to old friends: a central role of inducible NO synthase for progenitor cell recruitment and a new antiinflammatory mechanisms of statins. Brandes RP Circ Res; 2006 Feb; 98(3):303-5. PubMed ID: 16484625 [No Abstract] [Full Text] [Related]
14. Atherosclerosis, inflammation, leukocyte function and the effect of statins. Meyer-Sabellek W; Brasch H J Hypertens; 2006 Dec; 24(12):2349-51. PubMed ID: 17082713 [No Abstract] [Full Text] [Related]
15. [The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes]. Cecha J; Drabek G; Błazelonis A; Romanowski W; Zubelewicz-Szkodzińska B Wiad Lek; 2004; 57(5-6):255-8. PubMed ID: 15518071 [TBL] [Abstract][Full Text] [Related]
17. [The pleiotropic effects of statins]. Wolfovitz E Harefuah; 2005 Aug; 144(8):577-82, 597. PubMed ID: 16146158 [TBL] [Abstract][Full Text] [Related]
18. Statins: another class of antihypertensive agents? Milionis HJ; Liberopoulos EN; Achimastos A; Elisaf MS; Mikhailidis DP J Hum Hypertens; 2006 May; 20(5):320-35. PubMed ID: 16511505 [TBL] [Abstract][Full Text] [Related]
19. The inflammation hypothesis and its potential relevance to statin therapy. Forrester JS; Libby P Am J Cardiol; 2007 Mar; 99(5):732-8. PubMed ID: 17317382 [TBL] [Abstract][Full Text] [Related]
20. Fluvastatin and fluvastatin extended release: a clinical and safety profile. Asberg A; Holdaas H Expert Rev Cardiovasc Ther; 2004 Sep; 2(5):641-52. PubMed ID: 15350166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]